Bone Metastases: Clinical Trials

171 trials for Bone Metastases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

77 completed, 35 unknown, 19 recruiting, 16 terminated. 51 Not applicable, 37 Phase 2, 21 Phase 3, 15 Phase 1, 5 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable51Unknown 16, Completed 15, Terminated 5, Active not recruiting 4, Recruiting 4, Withdrawn 4, Not yet recruiting 2, Enrolling by invitation 1
Phase 237Completed 19, Terminated 6, Unknown 5, Recruiting 3, Active not recruiting 2, Not yet recruiting 1, Withdrawn 1
Phase 321Completed 15, Recruiting 2, Unknown 2, Not yet recruiting 1, Terminated 1
Phase 115Completed 7, Terminated 3, Unknown 3, Recruiting 1, Withdrawn 1
Phase 45Completed 3, Enrolling by invitation 1, Unknown 1
Early Phase 14Completed 3, Unknown 1

Follow Bone Metastases: new trials by email Literature Review of Bone Metastases trials Research Report on Bone Metastases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Regional Database for Collecting Clinical-biological and Imaging Data "Secondary Bone Oncology and Bone Localizations of Hematologic Diseases"
Bone Metastases
WithdrawnUniversity Hospital, Lille2026-12-012026-05-15
Impact of Prophylactic Bone Radiation Therapy in Patients With Bone Metastases.
prophylactic radiation, standard of care - Bone Metastases
Phase 3Not yet recruitingCentre Henri Becquerel1542026-09-012026-07-29
Surgery vs. No Surgery for Primary Tumor in De Novo Stage IV Breast Cancer With Solitary Bone Metastases
Primary Tumor Resection, Standard systemic therapy - Breast Cancer, Stage IV Breast Cancer
Not applicableNot yet recruitingWest China Hospital2162026-09-012026-07-07
Prophylactic Radiotherapy to Prevent Bone Complications in Patients With Metastatic Solid Cancers
Prophylactic External Beam Radiotherapy, Standard of Care - Bone Metastases, Metastatic Solid Tumor
Phase 2RecruitingInstitute of Oncology Ljubljana902026-06-022026-10-09
Denosumab Strategy for Liver Cancer With Bone Metastases
Denosumab, Sintilimab, Delayed/Rescue Bone-Modifying Strategy - Hepatocellular Carcinoma (HCC), Bone Metastases
Phase 2Not yet recruitingTongji Hospital502026-05-012026-04-17
Registry for Bone Metastases
Bone Metastases
RecruitingMemorial Sloan Kettering Cancer Center5002026-01-132026-08-20
Simulation-Free, Single-Fraction Palliative Radiation Therapy for Treatment of Bone Metastases
simulation-free, single-fraction palliative radiation therapy - Bone Metastases
Not applicableRecruitingUniversity of Utah402025-11-032026-08-13
Validation of Whole Body PET/CT Foundation Model
Bone Metastases
Not yet recruitingShanghai 6th People's Hospital1802025-10-162025-10-03
Dual Energy CT - a Tool for Delineation of Tumor and Organs at Risk in Radiotherapy
Dual-energy CT (DECT), Iodine-based contrast agent, Magnetic Resonance Imaging (MRI) - Brain Metastases, Bone Metastases
Not yet recruitingAalborg University Hospital802025-09-222025-09-22
BOne Metastases REgistry for Patients Undergoing cryoAbLation With curatIve purpoSe
Cryoablation system - Bone Metastases
RecruitingCardiovascular and Interventional Radiological Society of Europe502025-04-012025-12-30
Early Radiotherapy Versus Observation for High-risk Asymptomatic or Minimally Symptomatic Bone Metastases
Preventive radiotherapy, Systemic therapy (Standard of Care)/Observation - Solid Neoplasms, Bone Metastases
Not applicableRecruitingCancer Research Antwerp1202025-02-052026-01-20
EXercise Enhancement After RadioTherapy for Bone Metastases
Exercise Program - Bone Metastases
Not applicableEnrolling by invitationUniversity Health Network, Toronto202025-01-132026-04-13
Risk Model for Metastasis Detection of Neuroblastoma
risk model in diagnosis and prognosis - Neuroblastoma (NB), Prognosis
Enrolling by invitationXinhua Hospital, Shanghai Jiao Tong University School of Medicine5002024-12-012025-05-15
Fracture Risk Evaluation of Bone Metastases Derived From Carcinoma
Analysis - Bone Metastases
RecruitingCostantino Errani2502024-09-232025-12-15
EPIBONE Study: a Prospective Study on Feasibility, Safety and Accuracy
CT-guided bone percutaneous procedure - Bone Metastases, Fractures, Bone
Not applicableCompletedQuantum Surgical342024-09-162025-09-22
Tislelizumab Combined with Nab-Paclitaxel for First-Line Treatment of Advanced Triple-Negative Breast Cancer with Bone Metastasis,an Exploratory, Single-Arm, Multicenter Phase II Clinical Study
Tislelizumab + Nab-Paclitaxel, Rankl inhibitor - Triple-negative Breast Cancer, Bone Metastases
Phase 2RecruitingZhejiang Cancer Hospital202024-08-202024-11-26
A Study for Dynamic Prediction Model of Breast Cancer Bone Metastases
Breast cancer patients with bone metastasis, Breast cancer patients without bone metastasis - Breast Cancer, Bone Metastases
UnknownCancer Institute and Hospital, Chinese Academy of Medical Sciences35002024-08-062024-08-09
Safety of ArcBlate MRgHIFU in Patients With Painful Bone Metastases: An Extension Study
ArcBlate Focused Ultrasound Ablation System - Bone Metastases
Not applicableUnknownEpiSonica252024-08-012024-07-05
MR Guided Focused Ultrasound vs Radiotherapy for Palliative Pain Tx in Bone Metastases
MR- High intensity focused ultrasound, External beam radiotherapy - Bone Metastases
Not applicableWithdrawnStanford University2024-06-012024-10-01
Analysis of Intramedullary Nail and Prosthetic Reconstruction After Surgical Treatment of Bone Metastases of Proximal Femur
Analysis - Bone Metastases
RecruitingCostantino Errani6002024-05-302026-05-22

Showing 20 of 171. Sign in to see all of them.

Narrower conditions

Breast Neoplasms (30)  ·  Prostatic Neoplasms (27)  ·  Neoplasms (17)  ·  Bone Neoplasms (16)  ·  Neoplasm Metastasis (15)  ·  Pain (14)  ·  Lung Neoplasms (12)  ·  Cancer Pain (6)  ·  Carcinoma, Non-Small-Cell Lung (5)  ·  Fractures, Bone (5)  ·  Multiple Myeloma (5)  ·  Sarcoma (5)  ·  Bone Diseases (3)  ·  Carcinoma, Hepatocellular (3)  ·  Fractures, Spontaneous (3)

Broader conditions

Neoplasms (72)  ·  Neoplasms by Site (72)  ·  Pathological Conditions, Signs and Symptoms (33)  ·  Breast Diseases (31)  ·  Skin Diseases (31)  ·  Skin and Connective Tissue Diseases (31)  ·  Male Urogenital Diseases (30)  ·  Urogenital Diseases (30)  ·  Urogenital Neoplasms (29)  ·  Genital Diseases (27)  ·  Genital Diseases, Male (27)  ·  Genital Neoplasms, Male (27)  ·  Prostatic Diseases (27)  ·  Signs and Symptoms (21)  ·  Pathologic Processes (20)

Interventions

Zoledronic Acid (10)  ·  Denosumab (9)  ·  radium Ra 223 dichloride (9)  ·  Radiotherapy (5)  ·  Magnetic Resonance Spectroscopy (4)  ·  Radiation (4)  ·  Radiosurgery (4)  ·  Radium-223 (3)  ·  Technetium Tc 99m Medronate (3)  ·  enzalutamide (3)  ·  2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole (2)  ·  Aspirin (2)  ·  Cryosurgery (2)  ·  Enoxaparin (2)  ·  Fracture Fixation, Internal (2)

Sponsors

M.D. Anderson Cancer Center (7)  ·  InSightec (6)  ·  Bayer (5)  ·  UMC Utrecht (5)  ·  Amgen (4)  ·  Fudan University (4)  ·  Istituto Ortopedico Rizzoli (4)  ·  National Cancer Institute (NCI) (4)  ·  Shanghai 6th People's Hospital (4)  ·  Hospices Civils de Lyon (3)  ·  Assiut University (2)  ·  City of Hope Medical Center (2)  ·  Costantino Errani (2)  ·  EpiSonica (2)  ·  European Institute of Oncology (2)

Countries

United States (47)  ·  China (19)  ·  France (19)  ·  Italy (19)  ·  Canada (16)  ·  Netherlands (13)  ·  Belgium (9)  ·  Switzerland (9)  ·  Germany (7)  ·  United Kingdom (7)  ·  Austria (5)  ·  Brazil (5)  ·  Denmark (5)  ·  Israel (5)  ·  Spain (5)

Top investigators

Andre Bergman, MD, PhD (2)  ·  Francesco Cellini, MD (2)  ·  Helena M. Verkooijen, MD, PhD (2)  ·  Naoto Ueno, MD, PhD (2)  ·  Wilfried De Neve, MD, PhD (2)  ·  A KL Reyners, MD, PhD (1)  ·  AeRang Kim, MD, PhD (1)  ·  Ajjai Alva, M.D. (1)  ·  Alessio G Morganti, MD (1)  ·  Alexander de Graeff, MD, PhD (1)  ·  Alfredo Berruti, MD (1)  ·  Alysa Fairchild (1)

Results publications

PMID 22975218, PMID 23975226, PMID 26093811, PMID 27871280, PMID 18846565, PMID 20171515, PMID 20879569, PMID 21489705, PMID 22341993, PMID 23164174, PMID 24890347, PMID 25175042, PMID 25407874, PMID 25976743, PMID 26335402, PMID 26829933, PMID 27441744, PMID 29156912, PMID 33270906, PMID 18777528, PMID 19455472, PMID 20882405, PMID 21936956, PMID 22894553, PMID 22932804, PMID 23000088, PMID 23096187, PMID 23104043, PMID 23326203, PMID 23791392, PMID 23863050, PMID 23977665, PMID 24052017, PMID 24258798, PMID 24327518, PMID 24510426, PMID 24590644, PMID 24610703, PMID 24722180, PMID 24760791, PMID 24772219, PMID 24775727, PMID 24836273, PMID 24857093, PMID 24881730, PMID 24885354, PMID 25439694, PMID 25687533, PMID 25759599, PMID 25832684

NIH funding

2004 (1), 2008 (1), 2009 (1), 2014 (1), 2015 (1), 2016 (1), 2017 (1), 2018 (1), N01CM17101 (1), N01CM17102 (1), N01CM37120 (1), P30CA006516 (1), P30CA012197 (1), P30CA016059 (1), R01CA163870 (1)